Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NK/T-cell Lymphoma of Nasal Cavity”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)UnknownNCT04414969
What this trial is testing

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Who this might be right for
Immune Checkpoint InhibitorChemotherapy EffectEpigenetic Disorder+1 more
Hunan Cancer Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01007526
What this trial is testing

Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma

Who this might be right for
NK/T-cell Lymphoma of Nasal Cavity
Samsung Medical Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03728972
What this trial is testing

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Who this might be right for
NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis)NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)
Memorial Sloan Kettering Cancer Center 19